| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 81, 3197-3202, Copyright © 1996 by Endocrine Society
ARTICLES |
A Rabinovitch, WL Suarez-Pinzon, K Strynadka, JR Lakey and RV Rajotte
Department of Medicine, University of Alberta, Edmonton, Canada.
Cytokines produced by immune system cells infiltrating pancreatic islets are candidate mediators of islet beta-cell destruction in autoimmune insulin-dependent diabetes mellitus. Cytokine-induced islet beta-cell destruction may be mediated by reactive oxygen intermediates. To determine the possible roles of oxygen free radicals and nitric oxide (NO) as mediators of islet beta-cell destruction, we studied the relationships among cytokine-induced beta-cell destruction, production of malondialdehyde (MDA; an end product of lipid peroxidation), and production of nitrite (the stable end product of NO). The cytokine combination of interleukin-1 beta (50 U/mL), tumor necrosis factor- alpha (10(3) U/mL), and interferon-gamma (10(3) U/mL) induced significant increases in MDA and nitrite and significant decreases in insulin and DNA in islets after 60-h incubation. A novel antioxidant (lazaroid U78518E) significantly inhibited both a strong oxidant. t- butylhydroperoxide, and the combination of cytokines from inducing MDA production, but not from increasing nitrite production in the islets. Also, the lazaroid antioxidant significantly reversed the cytokine- induced decreases in insulin and DNA contents of the islet cultures. In contrast, L-NG-monomethyl arginine, an inhibitor of NO synthase, prevented cytokine-induced nitrite production, but did not prevent cytokine-induced increases in MDA and decreases in insulin and DNA in the islet cultures. In addition, the addition of MDA to the islets produced a dose-dependent decrease in their insulin and DNA contents, and this was only partially prevented by the lazaroid antioxidant. These results suggest that cytokines may be toxic to human islet beta- cells by inducing oxygen free radicals, lipid peroxidation, and aldehyde production in the islets, and that MDA is one of the cytotoxic mediators of cytokine-induced beta-cell destruction.
This article has been cited by other articles:
 |
|
 |
|
  A. I. Oprescu, G. Bikopoulos, A. Naassan, E. M. Allister, C. Tang, E. Park, H. Uchino, G. F. Lewis, I. G. Fantus, M. Rozakis-Adcock, et al. Free Fatty Acid Induced Reduction in Glucose-Stimulated Insulin Secretion: Evidence for a Role of Oxidative Stress In Vitro and In Vivo Diabetes, December 1, 2007; 56(12): 2927 - 2937. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kiely, N. H McClenaghan, P. R Flatt, and P. Newsholme Pro-inflammatory cytokines increase glucose, alanine and triacylglycerol utilization but inhibit insulin secretion in a clonal pancreatic {beta}-cell line J. Endocrinol., October 1, 2007; 195(1): 113 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Boudreau, H. W. Taylor, D. G. Baker, and J. C. Means Dietary Exposure to 2-Aminoanthracene Induces Morphological and Immunocytochemical Changes in Pancreatic Tissues of Fisher-344 Rats Toxicol. Sci., September 1, 2006; 93(1): 50 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. Barbe-Tuana, D. Klein, H. Ichii, D. M. Berman, L. Coffey, N. S. Kenyon, C. Ricordi, and R. L. Pastori CD40-CD40 Ligand Interaction Activates Proinflammatory Pathways in Pancreatic Islets Diabetes, September 1, 2006; 55(9): 2437 - 2445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. T. Hsu, L. Y. Tsai, S. K. Lin, J. K. Hsiao, and B. H. Chen Effects of diabetes duration and glycemic control on free radicals in children with type 1 diabetes mellitus. Ann. Clin. Lab. Sci., March 1, 2006; 36(2): 174 - 178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Mathews, W. L. Suarez-Pinzon, J. J. Baust, K. Strynadka, E. H. Leiter, and A. Rabinovitch Mechanisms Underlying Resistance of Pancreatic Islets from ALR/Lt Mice to Cytokine-Induced Destruction J. Immunol., July 15, 2005; 175(2): 1248 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Matsuda, K. Ferreri, I. Todorov, Y. Kuroda, C. V. Smith, F. Kandeel, and Y. Mullen Silymarin Protects Pancreatic {beta}-Cells against Cytokine-Mediated Toxicity: Implication of c-Jun NH2-Terminal Kinase and Janus Kinase/Signal Transducer and Activator of Transcription Pathways Endocrinology, January 1, 2005; 146(1): 175 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Kowluru and S. Odenbach Role of Interleukin-1{beta} in the Development of Retinopathy in Rats: Effect of Antioxidants Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4161 - 4166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Gurgul, S. Lortz, M. Tiedge, A. Jorns, and S. Lenzen Mitochondrial Catalase Overexpression Protects Insulin-Producing Cells Against Toxicity of Reactive Oxygen Species and Proinflammatory Cytokines Diabetes, September 1, 2004; 53(9): 2271 - 2280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tabatabaie, A. Vasquez-Weldon, D. R. Moore, and Y. Kotake Free Radicals and the Pathogenesis of Type 1 Diabetes: {beta}-Cell Cytokine-Mediated Free Radical Generation Via Cyclooxygenase-2 Diabetes, August 1, 2003; 52(8): 1994 - 1999. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. P. Bindokas, A. Kuznetsov, S. Sreenan, K. S. Polonsky, M. W. Roe, and L. H. Philipson Visualizing Superoxide Production in Normal and Diabetic Rat Islets of Langerhans J. Biol. Chem., March 7, 2003; 278(11): 9796 - 9801. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Azevedo-Martins, S. Lortz, S. Lenzen, R. Curi, D. L. Eizirik, and M. Tiedge Improvement of the Mitochondrial Antioxidant Defense Status Prevents Cytokine-Induced Nuclear Factor-{kappa}B Activation in Insulin-Producing Cells Diabetes, January 1, 2003; 52(1): 93 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes Endocr. Rev., October 1, 2002; 23(5): 599 - 622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bottino, A.N. Balamurugan, S. Bertera, M. Pietropaolo, M. Trucco, and J. D. Piganelli Preservation of Human Islet Cell Functional Mass by Anti-Oxidative Action of a Novel SOD Mimic Compound Diabetes, August 1, 2002; 51(8): 2561 - 2567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Marselli, F. Dotta, S. Piro, C. Santangelo, M. Masini, R. Lupi, M. Realacci, S. del Guerra, F. Mosca, U. Boggi, et al. Th2 Cytokines Have a Partial, Direct Protective Effect on the Function and Survival of Isolated Human Islets Exposed to Combined Proinflammatory and Th1 Cytokines J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4974 - 4978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Pileggi, R. D. Molano, T. Berney, P. Cattan, C. Vizzardelli, R. Oliver, C. Fraker, C. Ricordi, R. L. Pastori, F. H. Bach, et al. Heme Oxygenase-1 Induction in Islet Cells Results in Protection From Apoptosis and Improved In Vivo Function After Transplantation Diabetes, September 1, 2001; 50(9): 1983 - 1991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Johannesen, A. Pie, F. Pociot, O. P. Kristiansen, A. E. Karlsen, and J. Nerup Linkage of the Human Inducible Nitric Oxide Synthase Gene to Type 1 Diabetes J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2792 - 2796. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ho, N. Quan, Y.-H. Tsai, W. Lai, and T. M. Bray Dietary Zinc Supplementation Inhibits NF {{kappa}}B Activation and Protects Against Chemically Induced Diabetes in CD1 Mice Experimental Biology and Medicine, February 1, 2001; 226(2): 103 - 111. [Abstract] [Full Text]
|
|
|
|
|
|
E. Ho and T. M. Bray Antioxidants, NF{kappa}B Activation, and Diabetogenesis Experimental Biology and Medicine, December 1, 1999; 222(3): 205 - 213. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. HO, G. CHEN, and T. M. BRAY Supplementation of N-acetylcysteine inhibits NF{kappa}B activation and protects against alloxan-induced diabetes in CD-1 mice FASEB J, October 1, 1999; 13(13): 1845 - 1854. [Abstract] [Full Text]
|
|
|
|
|
|
P. Maechler, L. Jornot, and C. B. Wollheim Hydrogen Peroxide Alters Mitochondrial Activation and Insulin Secretion in Pancreatic Beta Cells J. Biol. Chem., September 24, 1999; 274(39): 27905 - 27913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yang, J. M. Egan, B. D. Rodgers, M. Bernier, and C. Montrose-Rafizadeh Differential Expression of a Novel Seven Transmembrane Domain Protein in Epididymal Fat from Aged and Diabetic Mice Endocrinology, June 1, 1999; 140(6): 2859 - 2867. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. B. Chausmer Zinc, Insulin and Diabetes J. Am. Coll. Nutr., April 1, 1998; 17(2): 109 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Scarim, M. R. Heitmeier, and J. A. Corbett Irreversible Inhibition of Metabolic Function and Islet Destruction after a 36-Hour Exposure to Interleukin-1{beta} Endocrinology, December 1, 1997; 138(12): 5301 - 5307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Flodstrom and D. L. Eizirik Interferon-{gamma}-Induced Interferon Regulatory Factor-1 (IRF-1) Expression in Rodent and Human Islet Cells Precedes Nitric Oxide Production Endocrinology, July 1, 1997; 138(7): 2747 - 2753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Delaney, D. Pavlovic, A. Hoorens, D. G. Pipeleers, and D. L. Eizirik Cytokines Induce Deoxyribonucleic Acid Strand Breaks and Apoptosis in Human Pancreatic Islet Cells Endocrinology, June 1, 1997; 138(6): 2610 - 2614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Burkart, H. Liu, K. Bellmann, D. Wissing, M. Jaattela, M. G. Cavallo, P. Pozzilli, K. Briviba, and H. Kolb Natural Resistance of Human Beta Cells toward Nitric Oxide Is Mediated by Heat Shock Protein 70 J. Biol. Chem., June 23, 2000; 275(26): 19521 - 19528. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
